Alternative Energy

Find premium alternative energy research reports. Purchase and download high quality report analysis, environmental reports, technology reports, alternative research reports, and much more

DocStore Search:
Per Page: 152550
  • Agensys, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Agensys, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Agensys, Inc. is a privately held biotechnology company engaged in developing a pipeline of therapeutic monoclonal antibodies (MAbs) for the treatment of solid tumor cancers. The Company is acquired by Astellas Pharma US, Inc. The company is headquartered in Santa Monica, California, the United States.
    View Document
  • Adams Respiratory Therapeutics, Inc. (ARXT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Adams Respiratory Therapeutics, Inc. (ARXT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Adams Respiratory Therapeutics, Inc. is a pharmaceutical company focused on late-stage development, commercialization and marketing of over-the-counter (OTC) and prescription pharmaceuticals for the treatment of respiratory disorders.
    View Document
  • Al Borg Laboratory SAE - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Al Borg Laboratory SAE - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Al Borg Laboratory (Al Borg) is a medical-laboratory, based in Egypt. The company operates through laboratory services. It conducts specialized tests that predicts, diagnose and monitor disease. The company conducts basic tests such as glucose testing for diabetes, and to the more complex molecular tests for hepatitis. It conducts research in national control of diarrheal diseases, national survey on hypercholesterolemia and multi drug trials with pharmaceutical companies such as Pfizer, Merck, Sharp & Dohme, Bristol Meyers Squibb, Rhone Poulenc Rorer and Janssen-Cilag. The company offers sample collection and delivery services which conducts tests for both conventional and non-conventional testing for other labs and individuals clients and also E-Services. Al Borg is headquartered in Cairo, Egypt.
    View Document
  • Avecia Biologics Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Avecia Biologics Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Avecia Biologics Limited (Avecia Biologics) is a biotechnology company, based in the UK. It is acquired by Nitto Dento. The company provides process development, Oligo manufacture, stability, validation and analytical services. Avecia Biologics produces oligonucleotide. It develops, qualifies, and validates analysis methods to ICH guidelines for raw materials, intermediates, adjuvants, and APIs. The services of company includes process and analytical development, pre-clinical and cGMPoligo manufacture, and quality control testing, including on site ICH stability storage and testing. It also provides services for DNA and RNA based therapeutics. The company was incorporated in fiscal year 2000. Avecia Biologics is headquartered in Blackley, Manchester, the UK.
    View Document
  • BioChem Solutions Inc. (BCHS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    BioChem Solutions Inc. (BCHS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    BioChem Solutions Inc. (BioChem Solutions) is a privately held development stage healthcare company, engaged in developing and commercializing treatment technologies for viral, fungal, bacterial and protozoa diseases and health conditions. It primarily focuses on HIV/AIDS and rheumatoid arthritis. The company has the global master license to produce and market medicines obtained from the patented products, namely, trioxolane and diperoxide. BioChem Solutions lead therapeutics includes alphamir, a prescription-only medicine targeting HIV/AIDS; and arthromeres, for the treatment of rheumatoid arthritis. Recently, the company has entered into an agreement with VitaPro International Ltd for the manufacture and distribution of BioChem product arthromir worldwide. The company is headquartered at Miami in Florida, the US.
    View Document
  • Aton Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Aton Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Aton Pharma, Inc. (Aton) is a privately held diversified specialty pharmaceutical company which is engaged in the provision of products for the treatment of life threatening diseases. The company is focused on ophthalmic diseases, orphan conditions and acute care hospital products. Aton offers products for the treatment of rare disease and ophthalmic diseases. The company caters patients, caregivers, and healthcare professionals. It has sales in more than 30 countries. The company launched new education, distribution, sampling and reimbursement programs for TIMOPTIC in OCUDOSE, the only preservative-free medication for glaucoma available in the US. Recently, the company Valeant has announced that it has signed an agreement to acqire Atom Pharma, Inc. The company is headquartered in Lawrenceville at New Jersey, the US.
    View Document
  • Archimedes Development Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Archimedes Development Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Archimedes Development Limited. (ADL) is a privately held pharmaceutical company. It is principally focused on the research and development of novel drug-delivery technologies for cancer pain. ADL products include Gliadel, a biodegradable wafer impregnated with an anti-cancer drug, carmustine, for high-grade glioma; Zomorph, an oral sustained release morphine product for cancer pain; Nozinan, a neuroleptic which possesses anti-emetic, antihistamine and anti-adrenaline activity and used to treat patients with cancer; and Pabrinex, a high potency formulation of vitamins B and C used to treat the symptoms of malnutrition especially in patients with acute alcohol problems. ADL is currently developing its products by using its proprietary drug delivery technologies, namely, ChiSys, PecSys and TARGIT. The company's key product, NasalFent is a fentanyl citrate nasal spray which is used in the treatment of cancer pain. In addition, the company markets its products in Germany and France. ADL operates as a wholly owned subsidiary of Archimedes Pharma Ltd. On 17th January, 2011 new treatment for breakthrough cancer pain accepted for use in Scotland. ADL is headquartered at Nottingham, the UK.
    View Document
  • American BioSciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    American BioSciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    American Biosciences, Inc. (ABI) is a pharmaceutical company, based in the US. The company manufactures, develops and markets nutritional dietary supplements for humans and pets. It manufactures nutrition supplements such as, FLEX solve for flexibility, mobility, and strength; CHOLESTSolve for lowering total and LDL cholesterol; SLEEP solve for sleep disorders; AveULTRA, a dietary supplement which contains avemar; ImmPower for healthy immune system; HP8 for healthy prostate function; SUGAR Solve for maintaining blood sugar. The company manufactures supplements products for animals which include dog-gone pain meant for revitalizing older dogs both physically and mentally; and NK-9 meant for healthy immune system for pets. It markets the products through its sales force and through its dealers. ABI is headquartered in Blauvelt, New York, the US.
    View Document
  • Artisan Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Artisan Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Artisan Pharma, Inc. (Artisan Pharma) is a privately held biotechnology company that is engaged in provision of critical-care and hospital-based therapeutics to patients, treating physicians, and payors in the US and internationally. The company's key product includes ART 123 a novel, recombinant, and soluble thrombomodulin for the treatment of disseminated intravascular coagulation in sepsis. Artisan Pharma offers its products in Japan, China, Taiwan, and Korea. In addition, the company has a strategic manufacturing alliance with A-Bio Pharma Pte Ltd. The company was formed as a partnership between a group of Asian and Western investors led by NGN Capital and Asahi Kasei Pharma Corporation Corporation (AKP). Artisan Pharma is headquartered at Waltham in Massachusetts, the US.
    View Document
  • Tokai Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Tokai Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Tokai Pharmaceuticals, Inc. (Tokai) is a biopharmaceutical company, based in the US. The company develops and markets endocrine-based therapies for the treatment of prostate cancer. It develops a drug candidate called galeterone (TOK-001) an investigational new drug, which can decrease overall androgen receptor levels in prostate tumors. Tokai also offers progesterone receptor modulators, which is a medical therapy for the treatment of uterine fibroids in women. The company provides semparatide a synthetic version of parathyroid hormone-related peptide for improved engraftment in hematopoietic stem cells transplantation in patients with multiple lymphoma or myeloma. Tokai is headquartered in Cambridge, Massachusetts, the US.
    View Document
  • Aquapharm Biodiscovery Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Aquapharm Biodiscovery Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Aquapharm Biodiscovery Limited (Aquapharm Biodiscovery) is a marine biotechnology company, based in the UK. The company discovers and develops pharmaceutical compounds. It develops biologically active pharmaceutical compounds for pharmaceutical, nutraceutical, personal care, and industrial applications. The company’s products include P-216, a narrow spectrum peptide antibiotic that exhibits potent and broad antimicrobial activity across a range of MRSA, VRSA, VISA, and VREs; and P-1639, a small molecule natural product derived from a marine fungus. It develops consumer/personal healthcare, nutrition, and biocatalysts products; antibiotics to treat gram negative and gram positive infections; and anti-oxidants and anti-inflammatories. Aquapharm Biodiscovery is headquartered in Argll, the UK.
    View Document
  • BioFocus - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    BioFocus - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    BioFocus (BioFocus) is a privately held contract research service provider. The company offers an array of contract research services supported by centralized project management. BioFocus provides a comprehensive suite of discovery products and services including integrated drug discovery, target discovery, assay development and screening, compound libraries, structural biology, in silico drug discovery, medicinal chemistry, compound management services. The company is the service division of Galapagos NV. Galapagos’ drug discovery division develops novel and disease-modifying drugs in a number of therapeutic areas. BioFocus provides integrated drug discovery that delivers pre-clinical drug candidates in all therapeutic areas with strong capability in neurodegenerative diseases, inflammatory diseases and with a growing track record of delivering candidates against rare and neglected diseases. Biofocus’ operations are spread over the markets of the US, the Netherlands, Switzerland, and Japan. BioFocus is headquartered in Essex, the UK.
    View Document
  • Aprecia Pharmaceuticals Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Aprecia Pharmaceuticals Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Aprecia Pharmaceuticals Company (Aprecia Pharmaceuticals) is a pharmaceutical service provider, based in the US. The company develops and manufactures therapeutically differentiated products that provide attractive market exclusivity for branded, generic and OTC pharmaceutical and neutraceutical partners. Its products include custom release, zipdose, nanodose, implantadose and other applications. The company offers products in the areas of pain and infectious diseases. It specializes in drug delivery, pharmaceutics, and product development, regulatory and manufacturing capabilities that produce a turn-key offering to partners for new products as well as life cycle management. The company uses its 3DP-related patent estate technology and provides long product life cycles on all 3DP products. Aprecia Pharmaceuticals is headquartered in Langhorne, Pennsylvania, the US.
    View Document
  • Voltalia (MLVLT) - Alternative Energy - Deals and Alliances Profile
    Voltalia (MLVLT) - Alternative Energy - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Voltalia (Voltalia) is a renewable energy company, based in France. The company designs, develops and operates power stations. It generates and distributes electricity through hydraulic, wind, biomass and solar. Voltalia operates as a global carbon credit operator on the voluntary and regulated markets. The company develops project under the clean development mechanism. It also develops an economic model that balances environmental, energy efficiency and harmonious development of North and South trade. The company generates and distributes renewable energy through its plants in French Guiana, Brazil and Greece. The company was incorporated in the year 1995. Voltalia is headquartered in Neuilly sur Seine, France. Voltalia (MLVLT) - Alternative Energy - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Alternative Energy eTrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table present
    View Document
  • ENERCON Services, Inc. - Power - Deals and Alliances Profile
    ENERCON Services, Inc. - Power - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    ENERCON Services, Inc. (ENERCON) is a provider of engineering, environmental and management services. The service line of the company includes nuclear plant operating license renewal, plant security, engineering design, licensing services, decommissioning services, document services, information management, waste management, site development and plant environmental compliance. In addition, the company serves nuclear sector by providing construction management, licensing and commissioning support services to develop and deploy new nuclear power plants. ENERCON serves various industrial sectors including nuclear, utilities, oil companies, manufacturers, financial services companies, aerospace, telecommunications, government agencies, universities and entertainment. The company operates through a network of 25 locations in the US, UAE and Belgium. ENERCON is headquartered in Kennesaw, Georgia, the US.
    View Document
Per Page: 152550